acCELLerate
- Company typePrivate
- Founded2000
- HeadquartersHamburg, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
acCELLerate firmographics
Firmographics- Name
- acCELLerate
- Legal name
- acCELLerate GmbH
- Website
- https://accellerate.me
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
acCELLerate industry classification
Industry- Product category
- Biotech Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Cell-Based & Potency Assays (Bioassays) (HLAGADAH)
- akta.pro secondary industries
- In Vitro Toxicology (Cell-based/Organ-on-chip) (HLAGAFAJ), Cell Therapy Quality, Analytics & Release Testing (potency, sterility, comparability) (HLAAABAK)
Keywords
Where acCELLerate is headquartered
LocationHeadquarters
- HQ city
- Hamburg
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
acCELLerate business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Custom Cell Banking Services: Custom cell banking projects including Master Cell Banks (MCB), Working Cell Banks (WCB), and assay-ready instaCELLs. Projects include cell line transfer, cultivation and freezing process implementation, and preparation of starting cell banks. Batch sizes range from 50 to 1,000 vials with custom aliquots from 1 million to 100 million cells.
- instaCELL Assay Kits: Pre-packaged kits combining assay-ready instaCELLs, plates, media, reagents, and controls with validated protocols. Includes cytotoxicity, skin sensitization, genotoxicity, pyrogen detection, and bioassay kits.
- Premium GMP Documentation Service: Comprehensive GMP-compliant documentation for analytical cell banks used in GMP-bioassays. Includes manufacturing batch records, quality reports with certificate of analysis (CoA), and certificate of conformity (CoC).
- Cell Storage Services: Custom storage for cell banks under properly controlled conditions with on-demand delivery and automatic replenishment of assay-ready instaCELLs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom cell banking projects are quote-based |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
acCELLerate product offering
Product offeringCore offering
acCELLerate produces and cryopreserves assay-ready cells (branded as instaCELLs) that can be used directly in cell-based assays without prior cultivation, functioning as consumable reagents. The company offers custom cell banking services (Master Cell Banks, Working Cell Banks, and large homogeneous assay-ready banks) for pharmaceutical and biotechnology clients, along with a portfolio of pre-validated assay kits for safety testing (cytotoxicity, skin sensitization, genotoxicity, pyrogen detection) and bioassay potency testing (TNF-α, G-CSF, GM-CSF, IL-2). It also supplies recombinant Assay Ready Cells (ARC) from partner AssayWorks for compound screening and lead identification.
Product overview
acCELLerate offers a portfolio of assay-ready cell products and custom cell banking services centered around their proprietary instaCELL technology. The core offering includes a comprehensive range of validated assay kits for safety testing (cytotoxicity, genotoxicity, skin sensitization, pyrogen detection) and bioassay potency testing (TNF-alpha, G-CSF, GM-CSF, IL-2), all featuring ready-to-use frozen cells that eliminate cell culture variability. Custom cell banking services provide Master Cell Banks (MCB), Working Cell Banks (WCB), and large homogeneous banks of assay-ready instaCELLs for pharmaceutical and biotechnology research. The ARC (Assay Ready Cells) line offers recombinant cell lines expressing receptors and ion channels for drug discovery screening applications. The company pioneered the assay-ready approach in Europe in the early 2000s and works with over 1,500 different cell lines.
Differentiator
Problem solved
Functional benefit
Brands
- instaCELL: Assay-ready frozen cells that can be used directly in assays without prior cultivation, essentially functioning as a reagent. Available in kit format for various testing applications including cytotoxicity, biocompatibility, skin sensitization, genotoxicity, and pyrogen detection.
Products and services
- instaCELL Cytotoxicity Assay Kit
Quantifiable outcome
- Improved assay precision through exclusion of cell culture variability
Companies that use acCELLerate
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
acCELLerate technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
acCELLerate partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- ATCCcoreacCELLerate has established a partnership with ATCC to produce custom cell banks from ATCC's authenticated cell lines for research clients in pharmaceutical and biotechnology sectors. The collaboration aims to enhance assay reproducibility and scalability for research and development of new pharmaceuticals.
- AssayWorkscoreAssayWorks, Germany developed recombinant cell lines expressing pharmaceutically relevant receptors and ion channels. acCELLerate provides these cell lines in assay ready format for compound screening, lead identification, and selectivity testing.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
acCELLerate competitors and assessment
Company assessmentDirect peers
- ATCC (American Type Culture Collection): Global biological resource provider offering authenticated cell lines and related services. Direct comparable in cell-line supply and custom cell banking, and is also a strategic partner of acCELLerate for authenticated lines.
- Cellular Technology Limited (CTL): Specializes in cryopreserved PBMCs and immune cell-based assay services (ELISpot, FluoroSpot). Comparable niche player focused on cryopreserved cells as reproducible assay inputs for immunology research.
- PromoCell: German provider of primary human cells, cell culture media, and cell-based assays. Closely comparable to acCELLerate in geography, target customer (pharma/cosmetics/medical device testing labs), and product portfolio.
- Cellero (BioLife Solutions): Supplies cryopreserved primary immune cells (PBMCs, NK cells, T cells) and related products for cell-based assays and cell therapy research. Highly comparable use case: turning cryopreserved cells into off-the-shelf assay reagents.
Broad incumbents
- Bio-Techne: Supplies proteins, antibodies, and cell-based assay reagents including GMP-grade cytokines and cell culture tools. Overlaps with acCELLerate on the reagent side of potency and bioassay workflows.
- Charles River Laboratories (HemaCare): Through HemaCare, supplies fresh and cryopreserved primary blood cells for research and cell therapy. Competes in the same cryopreserved-cell-for-assays market with the backing of a much larger CRO.
- Sartorius (CellGenix): Through CellGenix, supplies GMP-grade raw materials and cell-based assay reagents for cell and gene therapy manufacturing. Comparable in the GMP bioassay and ATMP/QC tooling space, though at much larger scale.
- Thermo Fisher Scientific (Gibco): Through its Gibco brand, supplies cell culture media, primary cells, and cell lines used in bioassays. Competes with acCELLerate across cell-based reagents and custom cell services, with much broader catalog and global reach.
- Lonza Group: Global cell and gene therapy CDMO with a large cell biology products portfolio. Overlaps with acCELLerate in custom cell banking and cell-based assay reagents, but at far greater scale and breadth.
- Eurofins Scientific: Global testing services group with significant cell-based assay, safety, and biocompatibility testing offerings. Competes with acCELLerate for outsourced cell-based testing and reagents, especially with safety testing labs.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
acCELLerate social profiles
Digital presenceacCELLerate compliance and trust
Trust signalCompliance1 record
acCELLerate financial estimates
Financial estimateRevenue estimate
Valuation estimate
acCELLerate leadership team
Management profileNumber of profiles
Profiles8 records
acCELLerate funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
acCELLerate M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about acCELLerate
What does acCELLerate do?
acCELLerate produces and cryopreserves assay-ready cells (branded as instaCELLs) that can be used directly in cell-based assays without prior cultivation, functioning as consumable reagents. The company offers custom cell banking services (Master Cell Banks, Working Cell Banks, and large homogeneous assay-ready banks) for pharmaceutical and biotechnology clients, along with a portfolio of pre-validated assay kits for safety testing (cytotoxicity, skin sensitization, genotoxicity, pyrogen detection) and bioassay potency testing (TNF-α, G-CSF, GM-CSF, IL-2). It also supplies recombinant Assay Ready Cells (ARC) from partner AssayWorks for compound screening and lead identification.
Is acCELLerate a public or private company?
acCELLerate is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was acCELLerate founded?
acCELLerate was founded in 2000. It employs 11 to 50 people.
Where is acCELLerate based?
acCELLerate is headquartered in Hamburg, Germany, in the Europe region.
How does acCELLerate make money?
Four revenue lines are on record. Custom Cell Banking Services are the primary driver. The others are instaCELL Assay Kits, premium GMP Documentation Service and cell Storage Services.
Who are acCELLerate's main competitors?
Direct peers on record are ATCC (American Type Culture Collection), Cellular Technology Limited (CTL), PromoCell and Cellero (BioLife Solutions). Broad incumbents are Bio-Techne, Charles River Laboratories (HemaCare), Sartorius (CellGenix), Thermo Fisher Scientific (Gibco), Lonza Group and Eurofins Scientific.
Does acCELLerate have an API?
No public API is recorded for acCELLerate.
What industry is acCELLerate in?
acCELLerate's product category is Biotech Reagents. Its primary akta.pro industry code is HLAGADAH, Cell-Based & Potency Assays (Bioassays), with a secondary code of HLAGAFAJ, In Vitro Toxicology (Cell-based/Organ-on-chip). Its NAICS code is 325413 and its SIC code is 2835.